32876502|t|Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
32876502|a|The current study aimed to develop alendronate (ALN)-loaded chitosan nanoparticles (CS-ALN-NPs) for brain delivery via intranasal route. These CS-ALN-NPs reduced the peripheral side effects and released ALN directly to brain. These NPs were formulated through ionic gelation technique by mixing sodium tripolyphosphate (1.5 mg/ml) in ALN-CS (1.75 mg/ml) solution. CS-ALN-NPs attained 135.75 +- 5.80 nm, 0.21 +- 0.013, 23.8 +- 3.69 mV, 72.46 +- 0.879% and 30.92 +- 0.375% mean particle size, PDI, zeta potential, entrapment efficiency and loading capacity, respectively. Furthermore, the TEM and SEM analysis of CS-ALN-NPs, respectively, revealed the particle size in 200 nm range and spherical shape. The in vitro and ex vivo release profile revealed a sustained drug release through CS-ALN-NPs as compared to pure drug solution. Also these NPs acquired a high concentration in mice brain and better pharmacokinetic profile than ALN solution (intranasal) CS-ALN-NPs were then evaluated against intracerebroventricular-streptozotocin (ICV-STZ) induced Alzheimer's disease (AD)-like pathologies in mice. The intranasal CS-ALN-NP altered the ICV-STZ induced neurobehavioral, neurochemical and histopathological changes in mice. These effects were significant to those of ALN solution (intranasal). The neuroprotective potential of CS-ALN-NPs observed in ICV-STZ mice model of AD may be a promising brain-targeted delivery system for AD treatment along with further extensive exploration at both pre-clinical and clinical edge. HIGHLIGHTS CS-ALN-NPs were developed and optimised to overcome the poor pharmacokinetic profile and associated side effects of ALN CS-ALN-NPs showed particle size within 200 nm range as well as controlled and sustained release in in vitro release study These optimised NPs of ALN attained higher brain:blood ratio and better pharmacokinetic profile (Cmax, tmax, AUC) CS-ALN-NPs markedly altered ICV STZ induced impairment in cognitive functions of mice and changes in APP processing, neuroinflammatory cytokines and other biochemical parameters in mice hippocampus.
32876502	44	52	chitosan	Chemical	MESH:D048271
32876502	70	81	alendronate	Chemical	MESH:D019386
32876502	90	109	Alzheimer's disease	Disease	MESH:D000544
32876502	137	151	streptozotocin	Chemical	MESH:D013311
32876502	213	224	alendronate	Chemical	MESH:D019386
32876502	226	229	ALN	Chemical	MESH:D019386
32876502	238	246	chitosan	Chemical	MESH:D048271
32876502	262	268	CS-ALN	Chemical	-
32876502	321	327	CS-ALN	Chemical	-
32876502	381	384	ALN	Chemical	MESH:D019386
32876502	473	496	sodium tripolyphosphate	Chemical	MESH:C005692
32876502	512	518	ALN-CS	Chemical	-
32876502	542	548	CS-ALN	Chemical	-
32876502	789	796	CS-ALN-	Chemical	-
32876502	962	969	CS-ALN-	Chemical	-
32876502	1056	1060	mice	Species	10090
32876502	1107	1110	ALN	Chemical	MESH:D019386
32876502	1133	1139	CS-ALN	Chemical	-
32876502	1196	1210	streptozotocin	Chemical	MESH:D013311
32876502	1216	1219	STZ	Chemical	MESH:D013311
32876502	1229	1248	Alzheimer's disease	Disease	MESH:D000544
32876502	1250	1252	AD	Disease	MESH:D000544
32876502	1274	1278	mice	Species	10090
32876502	1295	1301	CS-ALN	Chemical	-
32876502	1321	1324	STZ	Chemical	MESH:D013311
32876502	1397	1401	mice	Species	10090
32876502	1446	1449	ALN	Chemical	MESH:D019386
32876502	1506	1512	CS-ALN	Chemical	-
32876502	1533	1536	STZ	Chemical	MESH:D013311
32876502	1537	1541	mice	Species	10090
32876502	1551	1553	AD	Disease	MESH:D000544
32876502	1608	1610	AD	Disease	MESH:D000544
32876502	1713	1719	CS-ALN	Chemical	-
32876502	1829	1832	ALN	Chemical	MESH:D019386
32876502	1833	1839	CS-ALN	Chemical	-
32876502	1978	1981	ALN	Chemical	MESH:D019386
32876502	2069	2075	CS-ALN	Chemical	-
32876502	2101	2104	STZ	Chemical	MESH:D013311
32876502	2113	2146	impairment in cognitive functions	Disease	MESH:D003072
32876502	2150	2154	mice	Species	10090
32876502	2250	2254	mice	Species	10090
32876502	Negative_Correlation	MESH:D019386	MESH:D000544
32876502	Negative_Correlation	MESH:D019386	MESH:D048271
32876502	Positive_Correlation	MESH:D013311	MESH:D000544

